Cargando…
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924257/ https://www.ncbi.nlm.nih.gov/pubmed/27349387 http://dx.doi.org/10.1186/s12943-016-0534-2 |
_version_ | 1782439836058124288 |
---|---|
author | Miyazaki, Yumi Matsubara, Shyuichirou Ding, Qiang Tsukasa, Koichiro Yoshimitsu, Makoto Kosai, Ken-ichiro Takao, Sonshin |
author_facet | Miyazaki, Yumi Matsubara, Shyuichirou Ding, Qiang Tsukasa, Koichiro Yoshimitsu, Makoto Kosai, Ken-ichiro Takao, Sonshin |
author_sort | Miyazaki, Yumi |
collection | PubMed |
description | BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CSC-like properties of pancreatic cancer cells, in order to discover the key molecules controlling their unique properties. METHODS: Human pancreatic cancer cell lines, Capan-1, PANC-1, MIA PaCa-2 and Capan-1 M9 were used for our experiments in DMEM/F12 medium containing 10 % fetal bovine serum. Sphere formation assay, immunofluorescence staining, flow cytometric analysis and MTT cell viability assay were performed to investigate molecular signals and the efficacy in the treatment of pancreatic cancer cells. RESULTS: Inhibition of the Hh pathway significantly reduced the expression of stem cell marker CD133 and sphere formation, an index of self-renewal capacity, demonstrating the suppression of CSC-like properties. Moreover, the GLI inhibitor GANT61 induced greater reduction in sphere formation and cell viability of pancreatic cancer cells than the smoothened (SMO) inhibitor cyclopamine. This suggests that GLI transcription factors, but not SMO membrane protein, are the key molecules in the Hh pathway. The treatment using GANT61 in combination with the inhibition of mTOR, which is another key molecule in pancreatic CSCs, resulted in the efficient reduction of cell viability and sphere formation of an inhibitor-resistant cell line, showing the strong efficacy and wide range applicability to pancreatic CSC-like cells. CONCLUSIONS: Thus, this novel combination treatment could be useful for the control of pancreatic cancer by targeting pancreatic CSCs. This is the first report of the efficient elimination of pancreatic cancer stem-like cells by the double blockage of Hh/GLI and mTOR signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0534-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4924257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49242572016-06-29 Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition Miyazaki, Yumi Matsubara, Shyuichirou Ding, Qiang Tsukasa, Koichiro Yoshimitsu, Makoto Kosai, Ken-ichiro Takao, Sonshin Mol Cancer Research BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CSC-like properties of pancreatic cancer cells, in order to discover the key molecules controlling their unique properties. METHODS: Human pancreatic cancer cell lines, Capan-1, PANC-1, MIA PaCa-2 and Capan-1 M9 were used for our experiments in DMEM/F12 medium containing 10 % fetal bovine serum. Sphere formation assay, immunofluorescence staining, flow cytometric analysis and MTT cell viability assay were performed to investigate molecular signals and the efficacy in the treatment of pancreatic cancer cells. RESULTS: Inhibition of the Hh pathway significantly reduced the expression of stem cell marker CD133 and sphere formation, an index of self-renewal capacity, demonstrating the suppression of CSC-like properties. Moreover, the GLI inhibitor GANT61 induced greater reduction in sphere formation and cell viability of pancreatic cancer cells than the smoothened (SMO) inhibitor cyclopamine. This suggests that GLI transcription factors, but not SMO membrane protein, are the key molecules in the Hh pathway. The treatment using GANT61 in combination with the inhibition of mTOR, which is another key molecule in pancreatic CSCs, resulted in the efficient reduction of cell viability and sphere formation of an inhibitor-resistant cell line, showing the strong efficacy and wide range applicability to pancreatic CSC-like cells. CONCLUSIONS: Thus, this novel combination treatment could be useful for the control of pancreatic cancer by targeting pancreatic CSCs. This is the first report of the efficient elimination of pancreatic cancer stem-like cells by the double blockage of Hh/GLI and mTOR signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0534-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-27 /pmc/articles/PMC4924257/ /pubmed/27349387 http://dx.doi.org/10.1186/s12943-016-0534-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Miyazaki, Yumi Matsubara, Shyuichirou Ding, Qiang Tsukasa, Koichiro Yoshimitsu, Makoto Kosai, Ken-ichiro Takao, Sonshin Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title | Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title_full | Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title_fullStr | Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title_full_unstemmed | Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title_short | Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition |
title_sort | efficient elimination of pancreatic cancer stem cells by hedgehog/gli inhibitor gant61 in combination with mtor inhibition |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924257/ https://www.ncbi.nlm.nih.gov/pubmed/27349387 http://dx.doi.org/10.1186/s12943-016-0534-2 |
work_keys_str_mv | AT miyazakiyumi efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT matsubarashyuichirou efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT dingqiang efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT tsukasakoichiro efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT yoshimitsumakoto efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT kosaikenichiro efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition AT takaosonshin efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition |